BeStock  
Markets › Compare › KRYS vs HALO

KRYS vs HALO

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
KRYS · Krystal Biotech$308.89 ▼ 2.19%
HALO · Halozyme Therapeutics$91.35 ▼ 1.82%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

78104130157183Nov 24, '25May 26, '26Nov 20, '26
  • KRYS +43.7%
  • HALO +23.4%

Head to head

MetricKRYSHALO
Price$308.89$91.35
Change today▼ 2.19%▼ 1.82%
Market cap$9.15B$10.41B
Return, 3 months-9.6%-15.9%
Return, year to date+25.3%+35.7%
Return, 1 year+45.7%+29.9%
P/E (TTM)42.022.8
P/B6.4-188.4
P/E percentile vs own 5y68th65th
Dividend yield––
Revenue growth (YoY, latest qtr)+30.2%+39.2%
Net profit growth (YoY)-20.5%+41.0%
Gross margin94.3%82.3%
Operating margin48.4%55.9%
Net margin47.9%26.9%
Return on equity17.5%216.4%
Analyst target vs. price+27.3%+37.5%
Analyst buy share100%80%
RSI (14)4720
30-day volatility47.9%60.1%
Max drawdown, 1 year-21.8%-30.4%
Trend readLeaning bearishLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • HALO is the largest of the group by market value.
  • KRYS has returned the most over the past year.
  • HALO carries the lowest trailing P/E.
  • HALO is growing revenue fastest.
  • KRYS keeps the most profit per dollar of sales.
  • KRYS has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top